Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer by Tommaso P. Tonelli, Jens C. Eickhoff, Laura E. Johnson, Glenn Liu, Douglas G. McNeel

Get full text

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC) by Douglas G McNeel, Glenn Liu, Joshua M Lang, Ellen Wargowski, Hamid Emamekhoo, Mary Jane Brennan, Jens C Eickhoff, Laura E Johnson, Christos E Kyriakopoulos

Get full text

Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity by Jeremy D. Kratz, Shujah Rehman, Katherine A. Johnson, Amani A. Gillette, Aishwarya Sunil, Peter F. Favreau, Cheri A. Pasch, Devon Miller, Lucas C. Zarling, Austin H. Yeung, Linda Clipson, Samantha J. Anderson, Alyssa K. Steimle, Carley M. Sprackling, Kayla K. Lemmon, Daniel E. Abbott, Mark E. Burkard, Michael F. Bassetti, Jens C. Eickhoff, Eugene F. Foley, Charles P. Heise, Randall J. Kimple, Elise H. Lawson, Noelle K. LoConte, Sam J. Lubner, Daniel L. Mulkerin, Kristina A. Matkowskyj, Cristina B. Sanger, Nataliya V. Uboha, Sean J. Mcilwain, Irene M. Ong, Evie H. Carchman, Melissa C. Skala, Dustin A. Deming

Get full text